Ritholtz Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Ritholtz Wealth Management's HALO Position: Q3 2026 in Review
Ritholtz Wealth Management increased its Halozyme (HALO) stake by 17% in Q3 2026, buying an estimated $93.8K and bringing the position to 6,570 shares worth $725K. The position accounts for 0.01% of the portfolio, ranked #748.
Ritholtz Wealth Management first reported a position in HALO in Q3 2025 and has held it in 5 quarters since. The position peaked at $759K in Q4 2025. 768 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Ritholtz Wealth Management held 6,570 shares of Halozyme worth $725K as of Q3 2026.
- Ritholtz Wealth Management bought 971 Halozyme shares in Q3 2026, an estimated $93.8K.
- Halozyme made up 0.01% of Ritholtz Wealth Management's portfolio in Q3 2026, its #748 holding.
- Ritholtz Wealth Management first reported a position in Halozyme in Q3 2025 and has held it in 5 quarters since.
- Ritholtz Wealth Management's Halozyme position peaked at $759K in Q4 2025.
- 768 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.